James Alvarez

James Alvarez

Duke University

H-index: 21

North America-United States

About James Alvarez

James Alvarez, With an exceptional h-index of 21 and a recent h-index of 18 (since 2020), a distinguished researcher at Duke University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence

APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer

Immune cells in residual disease and recurrence

APOBEC mutagenesis inhibits breast cancer growth through induction of T cell–mediated antitumor immune responses

In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence

Therapy-Induced Dormancy and Residual Disease

Context-dependent effects of whole-genome duplication during mammary tumor recurrence

DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway

James Alvarez Information

University

Position

School of Medicine

Citations(all)

2753

Citations(since 2020)

1082

Cited By

2029

hIndex(all)

21

hIndex(since 2020)

18

i10Index(all)

25

i10Index(since 2020)

21

Email

University Profile Page

Google Scholar

Top articles of James Alvarez

Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence

Science Advances

2024/4/5

APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer

bioRxiv

2023/7/3

Immune cells in residual disease and recurrence

2023/7/1

APOBEC mutagenesis inhibits breast cancer growth through induction of T cell–mediated antitumor immune responses

Cancer immunology research

2022/1/1

In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence

NPJ Breast Cancer

2022/9/26

Therapy-Induced Dormancy and Residual Disease

2022/6/25

Context-dependent effects of whole-genome duplication during mammary tumor recurrence

Scientific reports

2021/7/22

DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway

Oncogene

2021/3/18

Abstract PO002: APOBEC mutagenesis as a driver of tumor evolution by promoting tumor recurrence and modulating tumor-immune system interactions in a syngeneic murine model of …

Cancer Immunology Research

2021/2/1

Jichun Xie
Jichun Xie

H-Index: 12

James Alvarez
James Alvarez

H-Index: 14

Epithelial-to-mesenchymal transition activates Bcat1 expression to promote recurrent tumor growth

bioRxiv

2020/12/9

G9a promotes breast cancer recurrence through repression of a pro-inflammatory program

Cell reports

2020/11/3

Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence

Nature communications

2020/10/6

RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence

Cell Death & Differentiation

2020/7

Adaptation and Selection Shape Clonal Evolution During Residual Disease and Recurrence

bioRxiv

2020/4/24

In vivo metabolic imaging reveals mitochondrial membrane potential reprogramming following Her2-targeted therapy and dormant disease

2020/4/20

Joy Duer
Joy Duer

H-Index: 2

James Alvarez
James Alvarez

H-Index: 14

NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism

Nature metabolism

2020/4

See List of Professors in James Alvarez University(Duke University)